q2K BHP
Black History Portal
THE BHP WIRE —
HIDDEN TRUTHS
What's New!
THE JOURNEY THROUGH TIME

Explore Black History

Explore the people, places, events, achievements, struggles and stories that shaped our journey.

✊🏾

Civil Rights

Movements, leaders, victories and the continuing fight for equality.

⚙️

Black Inventors

Innovation, patents, science, technology and world-changing contributions.

🏆

Sports

Pioneers, champions, Negro Leagues, records, activism and excellence.

♟️

People

Meet the people whose lives, choices and achievements shaped the journey.

📍

Places

Black towns, communities, institutions and places where history happened.

📜

Events

Moments that changed communities, movements, institutions and the nation.

Enter a person, place, event, or topic.
MY'STORY

The MOVE Fire

This is a personal recollection on the Move fire on May 13, 1985 Philadelphia police fired thousands of rounds at the MOVE house, city officials approved dropping an explosive device on the roof, the resulting fire was allowed to burn, 11 people—including five children—died, and 61 homes were destroyed. Philadelphia City Council later called it a “brutal attack carried out by the City of Philadelphia on its own citizens” and acknowledged that no individual faced criminal consequences for the bombing. One timeline correction worth preserving for the BHP record: the major previous MOVE-police confrontation was August 8, 1978, about seven years before the bombing, not a year or two earlier. Officer James Ramp was killed, other police and firefighters were wounded, nine MOVE members were later convicted, and television cameras recorded police beating Delbert Africa during his arrest. The 1985 MOVE Commission later specifically criticized city planners for failing to adequately use lessons from that 1978 confrontation. And that actually strengthens the point you’re making: 1985 did not happen without precedent or institutional memory. There had already been a deadly confrontation with MOVE, years of conflict, negotiations and police involvement before Osage Avenue.

MORE →
BLACK FACTS
The Truths They Never Taught You...

Shirley Chisholm — Unbought and Unbossed

In 1968 Shirley Chisholm became the first Black woman elected to the United States Congress. In 1972 she launched a campaign for the Democratic presidential nomination, breaking another political barrier.

MORE →
BHP gathered finds from its connected research sources. Showing the 4 strongest Black History matches.
← BACK TO RESULTS
Wikipedia

PPD, Inc.

PPD, Inc.
TypeSubsidiary
IndustryContract research organizations
Pharmaceutical
Biotechnology
Founded1985
HeadquartersWaltham, Massachusetts, United States
Key peopleSee Senior Leadership Team page of the PPD Website[1]
ProductsContract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include drug development, laboratory and lifecycle management.
RevenueIncrease $4.7 Billion (2020)[2]
Number of employees
40,000+ (2023)
ParentThermo Fisher Scientific
Websitehttps://www.ppd.com

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.

History

[edit]

PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year, he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.

In January 1989, the company incorporated in North Carolina.

In January 1996, PPD issued its initial public stock offering and began trading on the Nasdaq National Market System under the symbol PPDI.

In October 2005, PPD's board of directors adopted an annual cash dividend policy.

In July 2009, the company promoted Eshelman to executive chairman and names David Grange chief executive officer.[3] In January 2010, the company commemorated the 25th anniversary of its founding. In June the same year, PPD spun off its compound partnering division as a new and independent publicly traded company, Furiex Pharmaceuticals.[4]

A year later, in May 2011, David Grange retired as chief executive officer of PPD.[5] In September, PPD's board of directors named Raymond Hill as PPD's new chief executive officer.[6] In December of that year, the company was acquired by affiliates of The Carlyle Group and affiliates of Hellman & Friedman in an all-cash transaction valued at approximately $3.9 billion.[7]

In May 2012, PPD's board of directors named David Simmons as chairman and CEO.[8]

In August 2013, PPD acquired Acurian.[9]

In December 2014, PPD announced an agreement with SNBL to form a joint venture to provide full range of clinical development services in Japan.[10]

In May 2015, PPD expanded its network of U.S.-based research sites via strategic relationship with Radiant.

In June 2016, PPD expanded its network of global research sites via strategic relationship with Synexus. In September of that year, PPD acquired Evidera.[11]

In April 2017, Hellman & Friedman and affiliates of The Carlyle Group entered into definitive agreements to recapitalize PPD and expand the company's ownership to include two new investors, a subsidiary of the Abu Dhabi Investment Authority and an affiliate of GIC Private Limited, Singapore's sovereign wealth fund.[12]

In July 2018, PPD launched a new site solution.[13] In the same month, Synexus announced U.S.-based registry to power major longitudinal study on brain aging.[14]

In February 2019, PPD made a deal with China's HLT to create data science-driven research solutions.[15] In May of the same year, PPD's Evidera acquired RWE provider Medimix.[16] In September 2019, PPD's Accelerated Enrollment Solutions acquired global site business from Bioclinica.[17]

In February 2020, PPD issued its initial public stock offering and began trading on the Nasdaq Global Select Market under the symbol PPD.[18]

In April 2021, Thermo Fisher Scientific announced plans to acquire PPD for $17.4 billion.[19] The acquisition was complete in December 2021.[20][21]

References

[edit]
  1. ^ "Senior Leadership Team". Retrieved 11 May 2021.
  2. ^ https://www.macrotrends.net/stocks/charts/PPD/ppd/revenue [dead link]
  3. ^ Wayne Faulkner (May 19, 2009). "David Grange named CEO of PPD; Eshelman named executive chairman". Wilmington StarNews.[permanent dead link]
  4. ^ "PPD and Furiex Announce Completion of Spin-off". Retrieved 12 June 2018.
  5. ^ Wayne Faulkner (May 20, 2011). "David Grange retires as CEO of PPD". Wilmington StarNews. Archived from the original on August 15, 2014. Retrieved April 22, 2014.
  6. ^ "PPD appoints Raymond Hill as chief executive officer and member of the board of directors". 12 June 2018.[permanent dead link]
  7. ^ Peter Lattman (October 3, 2011). "Buyout Firms to Buy Drug Research Company for $3.9 Billion". New York Times.
  8. ^ William Faulkner (May 23, 2012). "PPD names new CEO". Wilmington StarNews. Archived from the original on April 2, 2015. Retrieved April 22, 2014.
  9. ^ "PPD Acquires Acurian, Industry Leader in Patient Recruitment and Retention". August 27, 2013. Archived from the original on July 13, 2018. Retrieved July 12, 2018.
  10. ^ John Murawski (December 24, 2014). "PPD enters into joint venture with Japanese company". The News & Observer.
  11. ^ Ben Adams (September 8, 2016). "PPD ties off Evidera merger deal, establishes 'real world research' leader". FierceBiotech.
  12. ^ PPD (April 26, 2017). "PPD to Recapitalize with Existing Owners and Investors".
  13. ^ Melissa Fassbender (July 2, 2018). "PPD flips the patient enrollment model and launches new site solution".
  14. ^ PPD (July 23, 2018). "Synexus Announces U.S.-Based Registry to Power Major Longitudinal Study on Brain Aging".
  15. ^ Joseph Keenan (February 28, 2019). "PPD inks deal with China's HLT to create data science-driven research solutions". FierceBiotech.
  16. ^ Melissa Fassbender (May 30, 2019). "PPD's Evidera acquires RWE provider Medimix". Outsourcing-Pharma.
  17. ^ PPD (September 5, 2019). "PPD's Accelerated Enrollment Solutions Acquires Global Site Business from Bioclinica".
  18. ^ Joshua Franklin (February 5, 2020). "Drug research firm PPD prices IPO at top end of target". Reuters.
  19. ^ "Thermo Fisher buying PPD in deal worth $17.4 billion". AP News. 2021-04-15.
  20. ^ "Thermo Fisher Scientific Completes Acquisition of PPD, Inc". PR newswire. 2021-12-08.
  21. ^ Still, Johanna F. (8 December 2021). "Thermo Fisher completes purchase of PPD". WilmingtonBiz. Retrieved 2026-09-28.
[edit]
  • Official website

Source: Wikipedia. Article content is retrieved live through the MediaWiki API.

Wikipedia

PPD, Inc.

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.

MORE →
Wikipedia

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021). It ranked 106th on the Fortune 500 list based on its 2025 annual revenue of $44.556 billion.

MORE →
No preview image
Wikipedia

PPD

PPD may refer to:

MORE →
Wikipedia

Syneos Health

Syneos Health (formerly InVentiv Health Incorporated and INC Research) is an American company that provides contract research and commercial services to pharmaceutical and biotechnology companies. Based in Morrisville, North Carolina, the company specializes in helping other companies with late-stage clinical trials, but also provides commercial services to market health treatments. Syneos Health was formed from the merger of InVentiv Health and INC Research, each formed from the consolidation of several companies in the contract research industry. It was listed on Nasdaq until 2023 when the company was taken private by Elliott Investment Management.

MORE →
TOPIC OF THE DAY

Greenwood / Black Wall Street

Before the 1921 destruction of Tulsa’s Greenwood District, Black residents had created a remarkable center of business and community life. The district included stores, professional offices, entertainment venues and homes owned by Black citizens. Understanding Greenwood means learning what was built—not only what was burned.

MORE →
TRIVIA QUESTION OF THE DAY

Which Supreme Court case ruled state-sponsored public-school segregation unconstitutional?

Brown v. Board of Education in 1954.